This search combines search strings from the content search (i.e. "Full Text", "Author", "Title", "Abstract", or "Keywords") with "Article Type" and "Publication Date Range" using the AND operator.
Beilstein J. Org. Chem. 2026, 22, 771–781, doi:10.3762/bjoc.22.59
Graphical Abstract
Scheme 1: Steroidal and nonsteroidal FXR agonists.
Scheme 2: ASK1 inhibitors.
Scheme 3: Dual FXR/ASK1 modulation strategy for MASH.
Scheme 4: Synthesis of compound 2. Conditions: (a) NH2OH·HCl, NaOH, EtOH/H2O, 70 °C, 12 h; (b) NCS, DMF, 40 °...
Scheme 5: Synthesis of compounds IXa–d. Conditions: (a) N2H4·H2O, MeOH, rt, 12 h; (b) DMF–DMA, 80 °C, 12 h; (...
Scheme 6: Synthesis of compounds Z1–15. Conditions: (a) K2CO3, KI, MeCN, 50 °C, 6 h, 86–96% yield; (b) Pd2(db...
Scheme 7: Synthesis of compounds Z16–29. Conditions: (a) Pd(PPh3)4, Na2CO3, 1,4-dioxane/H2O, 80 °C, 18 h, 64–...
Scheme 8: Synthesis of compound Z30. Conditions: (a) NaH, DMF, rt, 16 h; (b) TFA, DCM, 0 °C, 3 h; (c) Pd2(dba)...
Scheme 9: Molecular docking of dual-target modulator Z8 to the ligand binding sites of FXR (PDB ID: 3DCT, htt...
Figure 1: FXR agonist activity of all compounds. Results of the dual-luciferase reporter assay in CHO cells c...
Figure 2: ASK1 inhibition of all compounds. Results of the ADP-Glo™ kinase assay after treating ASK1 kinase w...
Figure 3: Effects of Z8 and Z30 on OA-induced lipid accumulation in HepG2 cells. Cells were treated with GW40...